Interactions between oxytocin and the basal ganglia are central in current overarching
conceptualizations of its broad modulatory effects on behavior. Whereas evidence from …

The key problem in treating cocaine addiction is the maintenance of a drug‐free state as
negative emotional symptoms during abstinence often trigger relapse. The mechanisms …

Approved pharmacological treatments for alcohol use disorder are limited in their
effectiveness, and new drugs that can easily be translated into the clinic are warranted. One …

Accumulating evidence indicates that the neuropeptide oxytocin (OXY) may modulate
reward-related behavioural responses to methamphetamine (METH) administration. Limited …

Methamphetamine (METH) abuse is characterised by chronic relapse and anxiety, for which
there are no effective pharmacotherapies. Acute treatment with the neuropeptide oxytocin …

Abstract Development of medications that attenuate symptoms of nicotine withdrawal may
be useful for facilitating smoking cessation. The neuropeptide oxytocin (OXY) decreases …

The neuropeptide oxytocin (OT) has a solid reputation as a facilitator of social interactions
such as parental and pair bonding, trust, and empathy. The many results supporting a pro …

The effects of oxytocin (OXT), arginine-and lysine-vasopressin (AVP and LVP) and an OXT-
receptor antagonist on cocaine-induced sniffing behaviour were investigated in rats. OXT …

Addictive drugs can profoundly affect social behaviour both acutely and in the long‐term.
Effects range from the artificial sociability imbued by various intoxicating agents to the …

Behavioural adaptation to and the effects of the neurohypophyseal peptide, oxytocin, on
repeated treatment with cocaine were investigated in rats. The content of immunoreactive …